Skip to main content

Table 5 Medication satisfaction rate

From: Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)

Medication Satisfaction (How much did you satisfy with the hypertensive drug treatment during last 8 weeks?)

STEP I (Baseline)

STEP II (Baseline)

STEP II (4 weeks)

STEP II (8 weeks)

N

12,223

2023

1928

1827

Extremely dissatisfied, 1 point, n (%)

68 (0.6)

25 (1.3)

11 (0.6)

12 (0.7)

Very dissatisfied, 2 points, n (%)

162 (1.3)

109 (5.4)

22 (1.1)

13 (0.7)

Somewhat dissatisfied, 3 Points, n (%)

718 (5.9)

563 (27.8)

90 (4.7)

44 (2.4)

Neither satisfied nor dissatisfied, 4 points, n (%)

1881 (15.4)

855 (42.3)

392 (20.3)

244 (13.4)

Somewhat satisfied, 5 points, n (%)

2250 (18.4)

205 (10.1)

653 (33.9)

582 (31.9)

Very satisfied, 6 points, n (%)

4370 (35.8)

173 (8.6)

619 (32.1)

748 (41.0)

Extremely satisfied, 7 points, n (%)

2774 (22.7)

93 (4.6)

141 (7.3)

184 (10.1)

Mean ± SD

5.5 ± 1.3

4.0 ± 1.2

5.1 ± 1.1

5.4 ± 1.0

p-value

  

< 0.0001a

< 0.0001b

  1. abaseline vs 4 weeks
  2. bbaseline vs 8 weeks
  3. Tested by paired t-test